مجله جهانی جراحی پلاستیک
مجله جهانی جراحی پلاستیک
دوشنبه 10 آذر 1404
[Archive]
چکیده: (264 مشاهده)
Gynecomastia, the excess growth of glandular breast tissue in males, is a common condition associated with hormonal imbalance or the use of certain drugs. Although medically benign, persistent gynecomastia often causes psychological distress and adversely affects quality of life. Published literature on the evaluation and management of patients seeking surgical treatment for gynecomastia is predominantly from Western populations. Here, we present insights from our practice in a multi-ethnic Asian population, with >550 cases treated at Amaris B. Clinic, Singapore from 2018–2023. We illustrate these insights and principles with a representative selection of 6 patient cases. We discuss specific considerations for optimizing the consultation process and outcomes in Asian patients, with reference to profiles commonly seen in our local setting. These were: adult males, the most encountered patient profile who are typically overweight/obese; young (adolescent) males, typically overweight, had a history of recent significant weight loss, or lean and experiencing gynecomastia due to puberty-related hormonal changes; males with drug-induced gynecomastia, typically athletes/bodybuilders. Our experience highlights several important considerations, including management of the consultation process, the range of patient expectations, and addressing surgical aspects of management to achieve the desired aesthetic outcomes.
نوع مطالعه: گزارش مورد |
موضوع مقاله:
تخصصي
فهرست منابع
1. Swerdloff RS, Ng JCM. Gynecomastia: Etiology, Diagnosis, and Treatment. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000.
2. Barros AC, Sampaio Mde C. Gynecomastia: physiopathology, evaluation and treatment. Sao Paulo Med J 2012;130(3):187-97. [DOI:10.1590/S1516-31802012000300009]
3. Ho SGY, Chan HHL. The Asian Dermatologic Patient. Am J Clin Dermatol 2009 2009/06/01;10(3):153-68. [DOI:10.2165/00128071-200910030-00002]
4. Chan IL, Cohen S, da Cunha MG, Maluf LC. Characteristics and management of Asian skin. Int J Dermatol 2019 Feb;58(2):131-43. [DOI:10.1111/ijd.14153]
5. Bayat A, Bock O, Mrowietz U, Ollier WE, Ferguson MW. Genetic susceptibility to keloid disease and hypertrophic scarring: transforming growth factor beta1 common polymorphisms and plasma levels. Plast Reconstr Surg 2003 Feb;111(2):535-43; discussion 44-6. [DOI:10.1097/01.PRS.0000041536.02524.A3]
6. Fanous N, Côté V, Fanous A. The new Genetico-Racial Skin Classification: How to maximize the safety of any peel or laser treatment on any Asian, Caucasian or Black patient. Can J Plast Surg 2011 Spring;19(1):9-16. [DOI:10.1177/229255031101900108]
7. McCurdy JA, Jr. Considerations in Asian cosmetic surgery. Facial Plast Surg Clin North Am 2007 Aug;15(3):387-97, vii. [DOI:10.1016/j.fsc.2007.05.001]
8. Sykes JM. Management of the aging face in the Asian patient. Facial Plast Surg Clin North Am 2007 Aug;15(3):353-60, vi-vii. [DOI:10.1016/j.fsc.2007.04.012]
9. American Society of Plastic Surgeons. ASPS Recommended Insurance Coverage Criteria for Third-Party Payers: Gynecomastia. 2002 (affirmed 2015); https://www.plasticsurgery.org/Documents/Health-Policy/Positions/Gynecomastia_ICC.pdf Accessed January 3, 2024
10. Chambers A. Management of Scarring Following Aesthetic Surgery. In: Téot L MT, Middelkoop E, et al.,, editor. Textbook on Scar Management: State of the Art Management and Emerging Technologies: Cham (CH): Springer; 2020; 2020. [DOI:10.1007/978-3-030-44766-3_45]
11.
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
